Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
14.73
-0.41 (-2.68%)
Nov 16, 2026, 4:00 PM EST - Market closed
Attovia Therapeutics Revenue
Attovia Therapeutics had revenue of $1.44M in the twelve months ending September 30, 2026. In the year 2025, Attovia Therapeutics had annual revenue of $1.35M. That makes Attovia Therapeutics the 43,048th largest company in the world by revenue and 5,938th in the United States.
Revenue (ttm)
$1.44M
Revenue Growth
n/a
P/S Ratio
466.82
Revenue / Employee
$32,727
Employees
44
Market Cap
672.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.35M | - | - |
| Dec 31, 2024 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ATTO News
- 6 days ago - Attovia price target raised to $34 from $30 at Citi - TheFly
- 6 days ago - Attovia price target raised to $40 from $39 at Morgan Stanley - TheFly
- 7 days ago - Attovia Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 7 days ago - Attovia Therapeutics Quarterly report: Q3 2026 - Filings
- 7 days ago - Attovia Therapeutics Earnings release: Q3 2026 - Filings
- 11 days ago - Attovia Therapeutics Transcript: KOL event & Study update - Transcripts
- 11 days ago - Attovia Therapeutics Press release: KOL event & Study update - Filings
- 11 days ago - Attovia Therapeutics Slides: KOL event & Study update - Filings